Mehmet Kilic1, Sema Ecin2, Erdal Taskin3, Askin Sen4, Murat Kara4. 1. Division of Allergy and Immunology, Department of Pediatrics, University of Firat, Elazig, Turkey. 2. Department of Pediatrics, Faculty of Medicine, University of Firat, Elazig, Turkey. 3. Division of Neonatology, Department of Pediatrics, University of Firat, Elazig, Turkey. 4. Department of Genetics, Faculty of Medicine, University of Firat, Elazig, Turkey.
Abstract
Background: The association between vitamin D receptor (VDR) polymorphisms and the risk of asthma remains unclear. This study aimed to investigate the effect of VDR gene polymorphisms and VDR mRNA expression levels on respiratory function, nitric oxide levels in expiratory air, and serum vitamin D levels in children with asthma. Materials and Methods: The study included 80 healthy children (control group) and 100 asthmatic children (asthma group) between the age of 5 and 18 years. The VDR genotypes (ApaI, TaqI, and FokI) and VDR mRNA levels were determined in all groups. Results: There was no statistically significant difference in vitamin D levels between the asthma group and the control group (P > 0.05). A significant association was found between both genotype (CC) of the TaqI polymorphism [odds ratio (OR) = 0.2, 95% confidence interval (CI) (0.07-0.5), P = 0.003] and genotype (CA) of ApaI polymorphisms [OR = 0.2, 95% CI (0.07-0.8), P = 0.02], and asthma risk. In addition, when single-nucleotide polymorphism allelic frequencies between asthma and control groups were compared there is no significant association (P > 0.05). When compared to control group, VDR mRNA expression in asthma group decreased in genotypes CC and CA of ApaI and in genotypes TT and TC of TaqI (P < 0.05). Conclusion: The results provide supporting evidence for an association between TaqI and ApaI polymorphisms and asthma susceptibility.
Background: The association between vitamin D receptor (VDR) polymorphisms and the risk of asthma remains unclear. This study aimed to investigate the effect of VDR gene polymorphisms and VDR mRNA expression levels on respiratory function, nitric oxide levels in expiratory air, and serum vitamin D levels in children with asthma. Materials and Methods: The study included 80 healthy children (control group) and 100 asthmatic children (asthma group) between the age of 5 and 18 years. The VDR genotypes (ApaI, TaqI, and FokI) and VDR mRNA levels were determined in all groups. Results: There was no statistically significant difference in vitamin D levels between the asthma group and the control group (P > 0.05). A significant association was found between both genotype (CC) of the TaqI polymorphism [odds ratio (OR) = 0.2, 95% confidence interval (CI) (0.07-0.5), P = 0.003] and genotype (CA) of ApaI polymorphisms [OR = 0.2, 95% CI (0.07-0.8), P = 0.02], and asthma risk. In addition, when single-nucleotide polymorphism allelic frequencies between asthma and control groups were compared there is no significant association (P > 0.05). When compared to control group, VDR mRNA expression in asthma group decreased in genotypes CC and CA of ApaI and in genotypes TT and TC of TaqI (P < 0.05). Conclusion: The results provide supporting evidence for an association between TaqI and ApaI polymorphisms and asthma susceptibility.
Authors: Audrey H Poon; Catherine Laprise; Mathieu Lemire; Alexandre Montpetit; Donna Sinnett; Erwin Schurr; Thomas J Hudson Journal: Am J Respir Crit Care Med Date: 2004-07-28 Impact factor: 21.405
Authors: Reinhold Vieth; Heike Bischoff-Ferrari; Barbara J Boucher; Bess Dawson-Hughes; Cedric F Garland; Robert P Heaney; Michael F Holick; Bruce W Hollis; Christel Lamberg-Allardt; John J McGrath; Anthony W Norman; Robert Scragg; Susan J Whiting; Walter C Willett; Armin Zittermann Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Tian-Tian Wang; Luz Elisa Tavera-Mendoza; David Laperriere; Eric Libby; Naomi Burton MacLeod; Yoshihiko Nagai; Veronique Bourdeau; Anna Konstorum; Benjamin Lallemant; Rui Zhang; Sylvie Mader; John H White Journal: Mol Endocrinol Date: 2005-07-07
Authors: G K Whitfield; L S Remus; P W Jurutka; H Zitzer; A K Oza; H T Dang; C A Haussler; M A Galligan; M L Thatcher; C Encinas Dominguez; M R Haussler Journal: Mol Cell Endocrinol Date: 2001-05-25 Impact factor: 4.102
Authors: M Wjst; G Fischer; T Immervoll; M Jung; K Saar; F Rueschendorf; A Reis; M Ulbrecht; M Gomolka; E H Weiss; L Jaeger; R Nickel; K Richter; N I Kjellman; M Griese; A von Berg; M Gappa; F Riedel; M Boehle; S van Koningsbruggen; P Schoberth; R Szczepanski; W Dorsch; M Silbermann; H E Wichmann Journal: Genomics Date: 1999-05-15 Impact factor: 5.736
Authors: André G Uitterlinden; Yue Fang; Joyce B J Van Meurs; Huibert A P Pols; Johannes P T M Van Leeuwen Journal: Gene Date: 2004-09-01 Impact factor: 3.688
Authors: Benjamin A Raby; Ross Lazarus; Edwin K Silverman; Steven Lake; Christoph Lange; Mathias Wjst; Scott T Weiss Journal: Am J Respir Crit Care Med Date: 2004-07-28 Impact factor: 21.405
Authors: Babatunji-William Ogunkolade; Barbara J Boucher; Jean M Prahl; Stephen A Bustin; Jacky M Burrin; Kate Noonan; Bernard V North; Nassima Mannan; Michael F McDermott; Hector F DeLuca; Graham A Hitman Journal: Diabetes Date: 2002-07 Impact factor: 9.461
Authors: Laura Tamasauskiene; Ieva Golubickaite; Rasa Ugenskiene; Nikolajs Sjakste; Natalia Paramonova; Lawrence Shih-Hsin Wu; Lawrence Shih-Jiu-Yao Wang; Brigita Sitkauskiene Journal: Immun Inflamm Dis Date: 2021-08-03